Free Float 70,22 %
Shares Float 35,29 M
Shares Outstanding 50,25 M
Taiko Pharmaceutical Co.,Ltd.
Share · JP3442200006 (XTKS)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Taiko Pharmaceutical Co.,Ltd.
No Price
Closing Price XTKS 28.04.2026:
293,00 JPY
28.04.2026 06:30
Current Prices from Taiko Pharmaceutical Co.,Ltd.
| Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
|---|---|---|---|---|---|
 Tokyo |
4574.T
|
JPY
|
28.04.2026 06:30
|
293,00 JPY
| 3,00 JPY
+1,03 %
|
Share Float & Liquidity
Invested Funds
The following funds have invested in Taiko Pharmaceutical Co.,Ltd.:
Fund | Vol. in million 6,35 | Percentage (%) 0,0034 % |
Fund | Vol. in million 2,59 | Percentage (%) 0,0034 % |
Company Profile for Taiko Pharmaceutical Co.,Ltd. Share
Taiko Pharmaceutical Co.,Ltd. engages in pharmaceuticals, infection control, and other businesses. The company manufactures and sells non-prescription drugs under the Seirogan and Seirogan Toi-A brands for the treatment of loose stools, diarrhea, food and water poisoning, vomiting, and related conditions; tablets for diarrhea; and quasi-drugs, such as Trumpet Intestinal Regulator BF. It also manufactures and sells sanitation control products under the Cleverin brand name to wholesalers, as well as Cleverin generator, a machine that emits low concentrations of chlorine dioxide gas; and supplies products using the patented Cleverin technology through OEM agreements and products developed jointly with other companies. It exports its products to the United States, Canada, Thailand, Vietnam, Malaysia, and Mongolia. Taiko Pharmaceutical Co.,Ltd. was incorporated in 1946 and is headquartered in Osaka, Japan.`
Company Data
Name Taiko Pharmaceutical Co.,Ltd.
Company Taiko Pharmaceutical Co.,Ltd.
Website
https://www.seirogan.co.jp
Primary Exchange
Tokyo
Tokyo
ISIN JP3442200006
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Takashi Shibata
Market Capitalization 15 Mrd.
Country Japan
Currency JPY
Employees 0,2 T
Address 1-4-1, Nishi-Honmachi, 550-0005 Osaka
IPO Date 2009-03-18
Dividends from 'Taiko Pharmaceutical Co.,Ltd.'
| Ex-Date | Dividend per Share |
|---|---|
| 29.12.2025 | 3,30 JPY |
| 29.12.2021 | 13,00 JPY |
| 29.06.2021 | 7,00 JPY |
| 29.12.2020 | 8,00 JPY |
| 29.09.2020 | 7,00 JPY |
| 30.03.2020 | 10,00 JPY |
| 27.09.2019 | 10,00 JPY |
| 27.03.2019 | 10,00 JPY |
| 26.09.2018 | 10,00 JPY |
| 28.03.2018 | 10,00 JPY |
Stock Splits
| Date | Split |
|---|---|
| 30.03.2020 | 3:1 |
| 28.07.2009 | 3:1 |
Ticker Symbols
| Name | Symbol |
|---|---|
| Tokyo | 4574.T |
More Shares
Investors who hold Taiko Pharmaceutical Co.,Ltd. also have the following shares in their portfolio:
